GE HealthCare Technologies Inc. with ticker code (GEHC) have now 9 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between 99 and 78 calculating the average target price we see $89.67. Now with the previous closing price of $69.31 this would indicate that there is a potential upside of 29.4%. The 50 day MA is $76.51 and the 200 day moving average is $74.56. The company has a market cap of 32.06B. The stock price for the company is currently is currently 70.48 USD
The potential market cap would be $41,473,811,842 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 19.52, revenue per share of 41.86 and a 5.77% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
